Bio-Tree Systems

Bio-Tree Systems

 

We welcome your interest in Bio-Tree, including our application for the oncology drug discovery industry, Bio-Tree PreClin, that expands our Vasculomics™ Platform to additional pre-clinical markets.

The Bio-Tree family also includes Bio-Tree Israel, a wholly owned subsidiary of Bio-Tree Systems, a U.S. Company. Bio-Tree Israel focuses on development of Vasculomics™ applications to be initially launched in the Israeli and European markets.